Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
2.950
-0.250 (-7.81%)
At close: Nov 19, 2026, 4:00 PM EST
3.270
+0.320 (10.85%)
After-hours: Nov 19, 2026, 4:24 PM EST
Lifeward Employees
Lifeward had 81 employees as of December 31, 2025. The number of employees increased by 1 or 1.25% compared to the previous year. That makes Lifeward the 32,734th largest employer in the world and 4,229th in the United States.
Employees
81
Change (1Y)
1
Growth (1Y)
1.25%
Revenue / Employee
$259,938
Profits / Employee
-$403,852
Market Cap
8.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 81 | 1 | 1.25% |
| Dec 31, 2024 | 80 | -28 | -25.93% |
| Dec 31, 2023 | 108 | 52 | 92.86% |
| Dec 31, 2022 | 56 | 5 | 9.80% |
| Dec 31, 2021 | 51 | 2 | 4.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 809 |
| Cytosorbents | 129 |
| IRIDEX | 93 |
| Pulsenmore | 71 |
| SANUWAVE Health | 55 |
| Modular Medical | 51 |
| PAVmed | 41 |
| Sintx Technologies | 32 |
LFWD News
- 3 days ago - Lifeward price target lowered to $8 from $10 at H.C. Wainwright - TheFly
- 6 days ago - Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 days ago - Lifeward Quarterly report: Q3 2026 - Filings
- 6 days ago - Lifeward Earnings release: Q3 2026 - Filings
- 5 weeks ago - Lifeward’s ReWalk exoskeleton shows sustained long-term home use in study - TheFly
- 5 weeks ago - Lifeward's ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study - GlobeNewsWire
- 7 weeks ago - Lifeward Proxy statement: Proxy filing - Filings
- 2 months ago - Peer-Reviewed Study of Lifeward's ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain - GlobeNewsWire